Lymphangioleiomyomatosis: Searching for potential biomarkers

Lymphangioleiomyomatosis: Searching for potential biomarkers

BackgroundVascular endothelial growth factor-D (VEGF-D) is the most commonly used biomarker for diagnosing lymphangioleiomyomatosis (LAM). However, lung biopsy is often necessary as well; therefore, defining new biomarkers for LAM is crucial. The aim of this study was to describe the diagnostic accu...

Full description

Bibliographic Details
Main Authors: Eva Revilla-López, Victoria Ruiz de Miguel, Manuel López-Meseguer, Cristina Berastegui, Meritxell Boada-Pérez, Alberto Mendoza-Valderrey, Marta Arjona-Peris, Marta Zapata-Ortega, Victor Monforte, Carlos Bravo, Antonio Roman, Susana Gómez-Ollés, Berta Sáez-Giménez
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Medicine
Subjects:
lymphangioleiomyomatosis
biomarkers
serum
metalloproteinases
VEGF-D
diagnose
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1079317/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1079317/full

Similar Items